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Background: Inhaled nanoparticles have been reported in some instances to translocate from the nostril to the
olfactory bulb in exposed rats. In close proximity to the olfactory bulb is the olfactory mucosa, within which resides
a niche of multipotent cells. Cells isolated from this area may provide a relevant in vitro system to investigate
potential effects of workplace exposure to inhaled zinc oxide nanoparticles.
Methods: Four types of commercially-available zinc oxide (ZnO) nanoparticles, two coated and two uncoated,
were examined for their effects on primary human cells cultured from the olfactory mucosa. Human olfactory
neurosphere-derived (hONS) cells from healthy adult donors were analyzed for modulation of cytokine levels, activation
of intracellular signalling pathways, changes in gene-expression patterns across the whole genome, and compromised
cellular function over a 24 h period following exposure to the nanoparticles suspended in cell culture medium.
Results: ZnO nanoparticle toxicity in hONS cells was mediated through a battery of mechanisms largely related to cell
stress, inflammatory response and apoptosis, but not activation of mechanisms that repair damaged DNA. Surface
coatings on the ZnO nanoparticles mitigated these cellular responses to varying degrees.
Conclusions: The results indicate that care should be taken in the workplace to minimize generation of, and exposure
to, aerosols of uncoated ZnO nanoparticles, given the adverse responses reported here using multipotent cells derived
from the olfactory mucosa.
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Zinc oxide (ZnO) nanoparticles have remarkable ultravio-
let (UV) absorbing, optical and optoelectronic properties
that make them valuable for a variety of commercial appli-
cations [1], including use in sunscreen products where
their transparency on the skin and the protection they
provide against broad-spectrum UV radiation [2,3] is of
consumer benefit. However, with increasing commercial
application comes the potential for increased workplace
exposure to airborne particles (reviewed in [4]). Inhalation* Correspondence: megan.osmond@csiro.au
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distribution, and reproduction in any mediumof ZnO fumes - which can include particles in the nano-
metre range - is associated with the onset of metal fume
fever, an illness characterized by transitory pulmonary and
systemic alterations in humans [5]. Recent in vivo studies
have reported the onset of oxidative stress, inflammation,
and lung injury following intratracheal instillation or inhal-
ation of ZnO nanoparticles in rats [6-9]. Numerous
in vitro experiments have also pointed to cell injury caused
by ZnO nanoparticles, or Zn2+ from partially dissolved par-
ticles (e.g. [10-14]). However, there are no known long-
term effects of ZnO fume inhalation, and there is some evi-
dence that, whilst initial exposures can induce a pulmonary
inflammatory response [15-17], humans may develop toler-
ance to inhaled ZnO fumes upon repeated exposure [18].ed Central Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Experimental overview. Nanoparticles were characterised
as powders or dispersions in aqueous media (top left), and also as
dispersions in DMEM cell-culture medium (top right). An initial
concentration response curve was generated to select an
appropriate treatment concentration that elicited a mechanistic
response in hONS cells for at least one of the ZnO products. hONS
cells were exposed to ZnO products at the selected concentration
(25 μg/mL) for up to 24 h, after which the cellular responses to
treatment were measured by a variety of assays. ‡ Cells from four
human donors, A, B, C and D, each in three replicate wells for each
treatment time-point (2 h, 6 h and 24 h); * Donor A cells, in three
replicate wells for each treatment time-point (2 h and 6 h); † Donor
A cells, in four replicate wells for each treatment time-point (2 h,
4 h, 6 h, 8 h, and 10 h); ** Donor A cells, in four replicate wells for
each treatment time-point (2 h and 6 h).
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of handling and to modulate their properties. For example,
coating facilitates their dispersability in the oil phase of
sunscreen formulations, as well as improving the texture of
the sunscreens on skin [19]. From a nanotoxicological per-
spective, stable surface coatings have been reported to sup-
press the generation of reactive oxygen species (ROS) by
ZnO nanoparticles [20,21] and may also decrease the pro-
pensity for ZnO nanoparticles to dissolve in biological en-
vironments. Thus, surface coating may mitigate two
postulated mechanisms of ZnO nanoparticle-mediated
cytotoxicity.
Following inhalation by rats, some types of nanoparticles
(graphite nanorods, manganese oxide and gold) have been
shown to accumulate in the olfactory bulb after depositing
on the olfactory mucosa and translocating along the olfac-
tory neuronal pathway [22-24]. This has led to interest in
the effects of nanoparticles on neural cells and brain func-
tion [13,25,26], as well as the potential application of this
pathway for drug delivery systems [27]. Within the olfac-
tory mucosa reside a niche of cells that, when cultured
in vitro, can form neurospheres that contain multipotent
cells that can differentiate to neurons and glial cells
[28-30]. Given the multipotent nature of this cell popula-
tion, as well as its proximity to a site of deposition of
nanoparticles following nasal inhalation, their response to
nanoparticle exposure is relevant in assessing the potential
for adverse effects following possible workplace exposure
to airborne nanoparticles.
Here, we have assayed the response of human olfac-
tory neurosphere-derived (hONS) cells established from
adult donors [31] to ZnO nanoparticles. To assess the
potential for altered cellular responses mediated by
different types of surface coatings, we tested two coated
and two uncoated (but different sized) ZnO nano-
particles. The ZnO nanoparticles selected for study are
all manufactured in large scale, available commercially,
and used in commercially-available products. For a
thorough assessment of the biological effects of these
ZnO nanoparticles, we employed a systems approach,
assaying a wide range of cellular responses – cytokine
release, cell-signalling, whole-genome transcriptional
profiling, and cell viability, stress and metabolism – to
determine whether early responses to ZnO exposure are
reflected by changes in cellular function.
We found that cells treated with the ZnO nanoparticles
showed generally robust and internally consistent re-
sponses across a wide range of biological endpoints, with
uncoated nanoparticles eliciting greater cellular stress and
cytotoxicity compared to coated ZnO nanoparticles. Fur-
ther, the surface coatings served to either delay, or
largely mitigate, the adverse cellular responses, depend-
ing on the composition, and possibly other characteris-
tics, of the coating.Results
A scheme summarising our experimental approach, in-
cluding particle characterisation and specific assays
used to measure cellular responses to the nanoparticles,
is shown in Figure 1. Four types of commercially-
available ZnO particles were assessed. Two were un-
coated (Z-COTE from BASF, and Nanosun P99/30
(hereafter referred to as Nanosun) from Micronisers)
and two were coated (Z-COTE HP1 and Z-COTE
MAX, both from BASF). Z-COTE HP1 (referred to as
HP1) is coated with triethoxycaprylylsilane, and Z-
COTE MAX (referred to as MAX) is coated with a
dimethoxydiphenylsilane/triethoxycaprylylsilane cross-
polymer. Our first experiments were nine cell stress and
viability assays (lower-right side of Figure 1), using
hONS cells derived from each of four human donors A,
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time-point were used for each assay. While some biological
variation was present between the four donors, treatment
effects typically far outweighed biological variations be-
tween the donors. For subsequent experiments (cytokine,
cell signalling, and whole-genome gene expression) we
used cells from donor A, where three to four replicate
wells for each treatment time-point were used. Thus, by
generating information on a very large number and variety
of endpoints, the systemic responses of hONS cells ex-
posed to commercial samples of coated and uncoated ZnO
nanoparticles could be identified.
Nanoparticle characterisation
The properties of particles can alter in a size-dependent
manner, and concomitant differences in induced cyto-
toxicity have been variously ascribed to physicochemical
characteristics including particle size, surface area,
shape, surface charge and free radical generation [32].
Therefore, we measured several physicochemical prop-
erties of the nanoparticles used for the cellular experi-
ments, as summarised in Table 1.
Particle size and shape
The three BASF products, Z-COTE, HP1 and MAX, are
typically rod-shaped, with heterogeneous sizes ranging up
to ~350 nm, as assessed by transmission electron micros-
copy (TEM). In general, the uncoated Z-COTE particles
are wider (average of 44 nm) and shorter (73 nm) than the
coated HP1 (28 nm, 96 nm) and coated MAX (36 nm,
95 nm) (Table 1). These sizes are broadly consistent with
the manufacturer’s specifications, which describe particle
size as <200 nm. In contrast, the uncoated Nanosun sam-
ple, from Micronisers, consists of mostly spheroidal parti-
cles, and shows a comparatively tighter size distribution
with an average particle diameter of 25 nm, consistent
with the manufacturer’s specifications (30 nm). The
morphology for each type of nanoparticle in its powder
form can be seen in TEM images, with their mean sizes
and size distributions indicated in box-plots, in Figure 2.
Specific surface area
From nitrogen-adsorption isotherms determined for
each ZnO sample in powder form, specific surface areas
of the ZnO samples were calculated using the Brunauer-
Emmett-Teller (BET) equation. Two sets of experiments
were performed independently by different operators using
different equipment; there were no substantial differences
between the two data sets. Consistent with its small size,
Nanosun had the largest surface area (30±3 m2/g, average
of the two measurements in Table 1), whereas Z-COTE
and HP1 were similar (13±2 and 14.9±0.5 m2/g, respect-
ively), and also very similar to MAX (12±1 m2/g) which
had the smallest surface area; the last three values are atthe lower end of the manufacturer’s specifications of
12–24 m2/g.
Surface coatings on HP1 and MAX
Analysis of elements in the two coated ZnO samples,
by ICP-AES (inductively coupled plasma atomic emis-
sion spectroscopy), revealed a larger percentage weight
of silicon in MAX (0.21%) compared with HP1 (0.17%),
indicating a greater number of silicon-containing,
surface-coating molecules in MAX than in HP1.
Thermogravimetric analyses (TGA) of the same sam-
ples, whereby changes in weight upon heating samples
to high temperatures are very accurately measured, re-
vealed total percentage weight losses that were greater
for MAX (2.15%) compared with HP1 (1.74%), consist-
ent with the thermal decomposition of more surface
molecules in MAX than HP1. Given that the coating on
MAX is a dimethoxydiphenylsilane-triethoxycaprylylsilane
crosspolymer while that on HP1 is pure triethoxy-
caprylylsilane, the molecular weight of dimethoxy-
diphenylsilane is less than triethoxycaprylylsilane, and the
specific surface area of MAX is slightly smaller than that of
HP1, the ICP-AES and TGA data reveal that MAX has more
surface-coating molecules per unit surface area than does
HP1. This could be manifested by MAX having a thicker coat-
ing than HP1, or a greater extent of surface coverage, or both.
Free radical generation
The nanoparticles dispersed in saline solution were
assessed by electron paramagnetic resonance (EPR) for
their ability to generate peroxynitrile or superoxide radi-
cals using TEMPONE-H as a spin trap. All samples gener-
ated these radicals above control levels, and all samples
generated more radicals in the presence of light than when
incubated in darkness. However, only Z-COTE was found
to generate statistically significant levels compared to the
negative control in both the light and the dark (Table 1).
In addition, Z-COTE generated levels of peroxynitrile and
superoxide radicals significantly higher than MAX, but
not HP1 or Nanosun, in the dark, and significantly higher
than HP1, MAX, and Nanosun in the light.
Detection of endotoxins on nanoparticles
Levels of endotoxin in all four ZnO products were below
detection limits (Table 1).
Characterisation of nanoparticles dispersed in water and
cell culture medium
When hydrodynamic size in water or DMEM cell-culture
medium was measured, the primary particle was rarely
seen, and, instead, particle agglomerates were detected as
measured by both dynamic light scattering (DLS) or differ-
ential centrifugation sedimentation (DCS) for all particle
types (Table 1). Of the four particle types, MAX formed
Table 1 Physical and chemical properties of the four types of ZnO nanoparticles
Z-COTE Nanosun HP1 MAX Media/H2O only
Powder
Coating None None Triethoxycaprylylsilane Dimethoxydiphenylsilane/
Triethoxycaprylylsilane crosspolymer
N/A
Batch number EHDA3001 4051 CNHE0602 FCHE1301 N/A
TEM mean primary size (nm) Width+: 44 ± 12 Diameter: 25 ± 1 Width: 28 ± 2 Width: 36 ± 2 N/A
Length: 73 ± 3 Length: 96 ± 6 Length: 95 ± 6
BET total surface area (m2/g) (#1) 14.5 32.5 14.4 10.8 N/A
BET total surface area (m2/g) (#2) 12.3 28.2 15.4 12.7
In H2O
Generation of peroxynitrile or Dark: 800 ± 300* Dark: 280 ± 80 Dark: 220 ± 40 Dark: 170 ± 50 N/A
superoxide radicals (% negative control) Light: 12,000 ± 3000* Light: 2000 ± 400 Light: 4000 ± 700 Light: 4,000 ± 300
Endotoxin BD BD BD BD N/A
DLS average particle size (nm)
(PDI in parenthesis)
0-time: 410 (0.34) 0-time: 600 (0.56) 0-time: 240 (0.25) 0-time: broad (0.96) 0-time: N/A
Zeta potential (mV) 0-time: 27 0-time: 9 0-time: -10 0-time: -7 0-time: -3
Altered pH (relative to H2O only) 0-time: -0.1 0-time: 0.0 0-time: -0.1 0-time: -0.1 0-time: N/A
In cell culture medium
(DMEM:F12, 1:1)
DLS average particle size (nm) over 0-time: 500 (0.54) 0-time: 240 (0.31) 0-time: 360 (0.36) 0-time: 150 (0.21) 0-time: 20 (0.39)
24 h (PDI in parenthesis) 2 h: 300 (0.47) 2 h: 350 (0.36) 2 h: 120 (0.17) 2 h: 150 (0.21) 2 h: 20 (0.42)
6 h: 400 (0.49) 6 h: 600 (0.57) 6 h: 100 (0.15) 6 h: 150 (0.21) 6 h: 20 (0.40)
24 h: 360 (0.36) 24 h: 440 (0.44) 24 h: 260 (0.28) 24 h: 203 (0.25) 24 h: 10 (0.39)
DCS particle size distribution (nm) 0-time: 100-900+ 0-time: BD 0-time: 150-900+ 0-time: 100-400 0-time: BD
Zeta potential over 24 h (mV) 0-time: -9 0-time: -8 0-time: -10 0-time: -7 0-time: -6
2 h: -8 2 h: -8 2 h: -8 2 h: -4 2 h: -6
6 h: -10 6 h: -8 6 h: -5 6 h: -6 6 h: -6
24 h: -13 24 h: -9 24 h: -6 24 h: -8 24 h: -6
Altered pH of media over 24 h
(relative to media only)
0-time: +0.1 0-time: -0.1 0-time: +0.1 0-time: +0.2 N/A
2 h: +0.2 2 h: 0.0 2 h: +0.1 2 h: -0.2
6 h: -0.1 6 h: +0.1 6 h: -0.1 6 h: 0.0
24 h: -0.2 24 h: 0.0 24 h: 0.0 24 h: 0.0
Nanoparticles were characterised as dry powders or as dispersions in either water or cell-culture medium. For measurements of hydrodynamic diameters of particles or agglomerates by DLS, polydispersity indices




















Figure 2 Nanoparticle morphologies and size distributions. TEM images of ZnO nanoparticles used in this study alongside boxplots showing
the distributions of particle lengths and widths (A. Z-COTE; B. HP1; C. MAX) or diameter (D. Nanosun), depending on whether particles were
mainly rod-shaped or spherical, respectively. 90–300 measurements were made for each dimension. The vertical line in the box represents the
median value and the edges of the box represent the lower and upper quartiles. The whiskers at the ends of the horizontal lines represent
minimum and maximum values. Scale bar for TEM images = 200 nm.
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culture medium, when initially dispersed. With increasing
time, both the coated particles, HP1 and MAX, formed
smaller agglomerates in medium compared with both
types of uncoated ZnO nanoparticles.
Both uncoated nanoparticles, Z-COTE and Nanosun,
had positive surface charges in water, while both coated
nanoparticles, HP1 and MAX, appeared to have negative
surface charges, as indicated by their zeta potentials
(Table 1). However, negative surface charges were observed
for all four products in cell culture medium, and these were
generally close to that observed for the medium itself, sug-
gestive of medium characteristics dominating over innate
particle surface charge.
The pH of solutions containing nanoparticles was typic-
ally found to be within −0.1 of nanoparticle-free water, and
within ±0.2 of cell culture medium over the 24 h incubation
under cell culture conditions, suggesting that the minimal
impact the nanoparticles may have had on pH was effect-
ively buffered by the medium (Table 1).
Selection of nanoparticle mass concentration used for
experiments with cells
All results described below are from experiments with cells
treated with an applied mass-equivalent concentration of25 μg/mL for each of the four different ZnO samples, and
compared with medium-only controls. This concentration
of 25 μg/mL was based on preliminary experiments that
showed measureable cellular cytotoxicity within the experi-
mental time-frame used here (Additional file 1: Figure S1).
Cytokine assays
Figure 3 shows levels of the pro-inflammatory cytokines
IL-6 and IL-8 secreted from hONS cells from donor A
after exposure to ZnO particles for 2 h and 6 h, relative
to levels in cells not exposed to nanoparticles, taken as
100%, for each time point. IL-6 and IL-8 were secreted
at levels significantly above those in untreated cells at
2 h and 6 h, respectively, in cells exposed to the coated
nanoparticle, MAX. IL-6 was also elevated in Nanosun-
treated cells at 2 h, but not in cells treated with Z-COTE
or HP1, where levels were not detected or were strongly
suppressed, respectively. By 6 h exposure, the levels of
IL-6 had dropped sharply in cells treated with Nanosun
and MAX to below those detected in untreated cells,
and levels in cells treated with Z-COTE and HP1 were
also well below those in untreated cells. Relative to no
treatment, IL-8 was strongly suppressed at both 2 h and
6 h exposure for all treatments except MAX. TNF-α,
TFN-β, IL-1β, IL-2, IL-4, IL-5, IL-10, IL-12 and IFN-γ
Figure 3 Levels of the cytokines IL-6 and IL-8 in hONS cells
treated with ZnO nanoparticles. hONS cells from donor A were
placed in three replicate wells for each ZnO treatment time-point
(2 h and 6 h). Results were averaged and expressed relative to levels
in time-matched untreated cells set as 100%. * Indicates statistical
significance relative to untreated cells.
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limit (20 pg/mL) for all treatments, consistent with pre-
vious work showing that the secretion of most of these
cytokines was not stimulated by ZnO nanoparticles [33].
Cell-signalling assays
hONS cells from donor A were tested for nanoparticle-
mediated activation of several cell-signalling pathways
by assaying the levels of phosphorylation (p) of key pro-
teins involved in those pathways (Figure 1). Activation
of MAPK/ERK pathways was assessed by measuring the
levels of pMEK and pERK (cell survival, growth and dif-
ferentiation), and pJNK, p-cJUN and p-p38 (inflamma-
tion, apoptosis, growth and differentiation). Activation
of the AKT signalling pathway, associated with cell
apoptosis and survival, was assessed by measuring the
levels of pAkt and pBAD. The NF-κB pathway, associ-
ated with cellular stress response, was assessed by meas-
uring the levels of pNF-κB and pI-κB. Perturbations of
DNA-damage response pathways were assessed by the
levels of pChk1, pChk2 and p-p53. Total (t) ERK, tAkt
and tI-κB levels were also monitored in the cellular ly-
sates, to ensure that the concentration of the signalling
proteins was not changing throughout the time course
of the experiments. Measurements were made in cells after
2, 4, 6, 8 and 10 h exposure. Results from all cell-signalling
experiments across all time-points are summarised in
Figure 4. As this 3D form of presentation cannot include
error bars, the data used to generate this figure, togetherwith standard errors of means and statistical significance,
are supplied separately in Additional file 2: Table S1.
Cells treated with the uncoated nanoparticles, Z-COTE
and Nanosun, or the coated nanoparticle, HP1, showed
similar cell-signalling profiles. Peaks of activity for both
uncoated nanoparticles were generally observed by 6 h
exposure, with signalling spikes diminishing thereafter,
possibly due to treatment-mediated cell death at later
time-points (see below). Peaks of activity for HP1-treated
cells often occurred slightly later than for cells treated with
either of the uncoated nanoparticles (Z-COTE, Nanosun),
suggesting a slightly delayed response to the coated HP1
nanoparticles. The cell survival, growth and differentiation
(pMEK, pERK) and inflammatory/apoptosis arms (pJNK,
p-cJUN, p-p38) of the MAPK/ERK signalling pathway
were the most strongly activated by these treatments
(shown as pathway III in Figure 4). The Akt (pAkt, pBAD)
and NF-κB (pNF-κB, pI-κB) signalling pathways were also
significantly activated (pathways IV and II, respectively, in
Figure 4), signifying that anti-apoptotic and inflammatory
pathways in addition to MAPK had been induced. These
cell stress/survival signalling pathways were also activated
in cells treated with the coated MAX, but to a much
smaller extent, rarely reaching statistical significance. The
signalling pathway for response to DNA damage (path-
way I, Figure 4) was not activated by any ZnO treatment.
Analysis of gene expression from microarray data
hONS cells from donor A were exposed to the four types
of ZnO particles for 2 h and 6 h, and levels of RNA tran-
scripts representing 28,869 genes were measured using
Affymetrix GeneChip Human Gene 1.0ST microarrays.
Microarray data are freely available on the GEO Archive
(http://www.ncbi.nlm.nih.gov/geo/) under accession num-
ber GSE45322.
The Canonical Pathways most significantly activated in
ZnO-treated cells compared to untreated cells were identi-
fied using Ingenuity Pathway Analysis (IPA) software. A
list of the five Canonical Pathways most perturbed by ex-
posure to each ZnO sample at 2 h and 6 h is shown in
Table 2, and maps of differential transcript activity are
given in Figure 5. In general, short exposures (2 h) to
ZnO nanoparticles activated pathways involved in cellu-
lar stress responses, whereas longer exposures (6 h)
perturbed pathways more related to cell injury and re-
pair. All ZnO products activated similar pathways at
2 h, and particularly up-regulation of the “Aldosterone
Signalling in Epithelial Cells Pathway” and the “NRF2-
Mediated Oxidative Stress Response Pathway” (Table 2).
The Aldosterone Signalling Pathway is implicated in the
activity of transport proteins, or possibly cellular differ-
entiation to modify electrolyte transport [34], and the
NRF2-Mediated Oxidative Stress Response Pathway is
associated with a cell survival response in the face of
Figure 4 Phosphorylation of key proteins from four major cell-signalling pathways in hONS cells treated with ZnO nanoparticles. hONS
cells from donor A were placed in four replicate wells for each ZnO treatment time-point (2, 4, 6, 8 and 10 h). Levels of phosphorylation of
proteins involved in the selected cell-signalling pathways in cell lysates were averaged and expressed as the percentage of time-matched
untreated cells set as 100%. The four cell-signalling pathways are I DNA Damage; II NFκB; III MAPK; IV AKT. Data used to generate this figure, and
associated standard errors of means and statistical significance, are supplied separately in Additional file 2: Table S1.
Table 2 Canonical pathways most significantly perturbed at the transcriptional level in hONS cells exposed to
ZnO nanoparticles
Particle Top 5 Canonical pathwaysperturbed at 2 h p - value
Top 5 Canonical pathways
perturbed at 6 h p value 2
Z-COTE uncoated Aldosterone signalling in epithelial cells 1.97E - 10 Nucleotide excision repair pathway 1.30E - 05
NRF2-mediated oxidative stress response 1.33E - 08 Endoplasmic reticulum stress pathway 2.75E - 04
Protein ubiquitination pathway 3.66E - 06 Protein ubiquitination pathway 6.82E - 04
Glucocorticoid receptor signalling 3.53E - 05 Ubiquinone bisoynthesis 9.82E - 04
Huntingtons’s disease signalling 7.91E - 05 Assembly of RNA Polymerase II complex 1.24E - 03
Nanosun uncoated Aldosterone signalling in epithelial cells 4.70E - 07 Ubiquinone biosynthesis 9.92E - 12
NRF2-mediated oxidative stress response 1.31E - 05 Mitochondrial dysfunction 4.00E - 11
IL-17A signalling in fibroblasts 6.40E - 05 Nucleotide excision repair pathway 5.92E - 11
Production of nitric oxide and reactive
oxygen species in macrophages
1.17E - 04 Oxidative phosphorylation 2.70E - 09
Glucocorticoid receptor signalling 1.87E - 04 Protein ubiquitination pathway 1.60E - 08
HP1 coated (Triethoxycaprylysilane) Aldosterone signalling in epithelial cells 4.12E - 07 Glucocorticoid receptor signalling 1.25E - 07
NRF2-mediated oxidative stress response 1.17E - 06 Aldosterone signalling in epithelial cells 5.85E - 06
Glucocorticoid receptor signalling 1.50E - 04 Protein ubiquitination pathway 8.79E - 06
IL - 17A signalling in fibroblasts 4.88E - 04 NRF2-mediated oxidative stress response 7.27E - 05
Protein ubiquitination pathway 9.24E - 04 Assembly of RNA Polymerase II complex 9.05E - 05
MAX coated (Dimethoxydiphenylsilane/
triethoxycaprylylsilane cross-polymer)
Aldosterone signalling in epithelial cells 7.40E - 04 Hereditary breast cancer signalling 6.11E - 06
NRF2-mediated oxidative stress response 1.01E - 03 Aminoacyl-tRNA biosynthesis 4.24E - 05
IL-10 signalling 2.71E - 03 Glucocorticoid receptor signalling 5.61E - 05
Protein ubiquitination pathway 2.85E - 03 Mismatch repair in eukaryotes 7.59E - 05
Endothelin-1 signalling 1.48E - 02 Nucleotide excision repair pathway 1.04E - 04
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Figure 5 Map of differential transcript activity in hONS cells treated with ZnO nanoparticles. hONS cells from donor A were assessed in
quadruplicate wells for each ZnO treatment time-point (2 h and 6 h). Differentially-expressed transcripts were grouped according to function,
ordered alphabetically within each function, and arrayed alongside one another for each of the treatment data sets. The sorted files were then
uploaded to the web-based prettygraph (www.prettygraph.com) to generate colour-coded maps for the aligned transcriptional profiles across all
treatments. Green indicates up-regulated transcripts, red indicates down-regulated transcripts, and black signifies little difference from untreated
cells (although still reaching statistical significance where p<0.05). White gaps signify treatments where transcripts were not differentially-
expressed relative to untreated cells. The bar at the right hand-side shows the colour-code for the magnitude of the log ratio.
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ised down-regulation of a diverse range of Canonical Path-
ways was observed, suggestive of an overall decrease in
transcription of specific genes potentially involved in these
pathways with longer exposures, although the overall
number of transcripts differentially regulated at 6 h was
greater than at 2 h.
Analysis at the transcript level revealed that the majority
(over 50%) of transcriptional changes for all treatments was
classified by the IPA system as “other”, and comprised gene
products including molecular chaperones, metallothioneins,
ribosomal proteins, and small nucleolar RNAs (Figure 5).
The other broad functional categories that were substan-
tially perturbed across all treatments comprised transcrip-
tion regulators, enzymes, and transporters. Several more
categories that were differentially regulated by treatment
with Z-COTE, Nanosun or HP1 at 2 h, such as ion chan-
nels, kinases, microRNAs and phosphatases, were not
perturbed in cells treated with MAX at the same time-point. By 6 h, however, both the range of categories and
relative proportions of genes therein were essentially identi-
cal for all - although there were differences at the level of
individual genes.
To gain a greater insight into the degree of transcriptional
variations between treatments, the numbers of unique or
shared transcripts across all treatments were counted and
plotted in four-way VENN diagrams (Figure 6). At 2 h, the
largest number of overlapping transcripts was shared be-
tween the uncoated particles (Z-COTE and Nanosun) and
the coated HP1 (56 shared transcripts). Thirty transcripts
were uniquely shared by Nanosun and Z-COTE, and 17
were shared by all treatments. However, the transcripts that
had been uniquely activated by the cytotoxic treatments (Z-
COTE, Nanosun, HP1) at 2 h, were also activated by MAX
at 6 h, and thus were not ultimately unique to a particular
ZnO product. In addition, when these reduced gene lists at
2 h were scrutinised, we found that they comprised tran-
scripts already flagged in Canonical Pathways previously
Figure 6 VENN diagrame showing numbers of unique or shared
transcripts within and between different ZnO treatments at 2 h
and 6 h. Numbers indicate differentially-expressed transcripts, graphed
according to whether they occurred uniquely within one treatment
(unshared VENN), or whether they were differentially activated by two or
more of the treatments (intersecting VENN). Blank intersections indicate
that no genes were unique to that intersection or treatment.
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ways specific to these intersecting genes were highlighted.
The total number of differentially-expressed genes was
overall much greater at 6 h than 2 h and, as might be
expected with such a large dataset, more genes populated
each intersect of the VENN diagram. Nevertheless, by far
the greatest number of genes that were differentially
expressed was largely shared by all treatments (2380 tran-
scripts). Furthermore, transcripts that were unique to indi-
vidual treatments or specific intercepts once again, and for
the same reasons as discussed above, did not convincingly
translate to unique pathways being activated by these treat-
ments when assessed by IPA, but simply appeared to con-
tribute to a stronger perturbation of pathways that had
already been identified.
Assays for cellular function
hONS cells from donors A, B, C and D were assessed for
viability after exposure to the four ZnO samples for 2, 6
and 24 h, using a range of functional indicators includingmetabolic activity, antioxidant capacity, proteasome activ-
ity, plasma membrane integrity, and apoptosis. Data from
the four donors were averaged and the results from all ex-
periments across all time-points are summarised in Fig-
ure 7. The data used to generate this figure, together with
standard errors of the mean and statistical significance,
are supplied separately in Additional file 3: Table S2.
As observed for the cell-signalling assays and transcrip-
tional profiles, treatment with the uncoated particles, Z-
COTE and Nanosun, or the coated HP1 induced highly
similar responses in terms of both magnitude of change
compared to untreated cells and spectrum of cellular func-
tions affected. The most substantial response observed
was the elevation of caspase 3–7 activity, indicative of in-
duction of apoptosis by 6 h exposure. The caspase-like
and trypsin-like proteasomal activities, associated with
targeted protein degradation, were also substantially stim-
ulated by these treatments. By 24 h exposure, cell mem-
brane disruption had risen as measured by an increase in
lactate dehydrogenase (LDH) activity in culture medium,
and cellular metabolic activity (adenosine triphosphate
(ATP) content, methanethiosulfonate (MTS) metabolism,
and proteasome activity) had sharply decreased, most
likely indicating cell death at this late time-point. In con-
trast, cells treated with the coated nanoparticle, MAX,
showed only a significant increase in MTS metabolism at
2 h, which had subsided to near control levels by 6 h, and
these cells were observed to have largely survived treat-
ment after 24 h exposure, as indicated by the control
levels of most cell functions at 24 h.
Discussion
The systemic responses of primary human olfactory
neurospheres to four types of commercially-available ZnO
nanoparticles are reported here. Two types of ZnO samples
had particles of different sizes and were uncoated (Z-
COTE and Nanosun), while the other two had particles
the same size as Z-COTE but bore different surface coat-
ings (HP1 and MAX), allowing the relative impacts of
particle size and applied surface coatings in commercially-
produced ZnO samples to be assessed. The responses elic-
ited in human olfactory neurosphere-derived (hONS) cells
by all four ZnO samples were generally robust and intern-
ally consistent across the comprehensive suite of biological
experiments employed, and also across four genetically dis-
tinct cell lines in nine cell-stress and viability assays. When
first exposed to ZnO nanoparticles, the cells initiated pro-
survival responses, generally independent of particle size
but slightly dependent on coating, while apoptotic pro-
cesses dominated after 24 h exposure to three of the ZnO
samples - the uncoated Nanosun and Z-COTE, and HP1
coated with triethoxycaprylylsilane. In contrast, cells ex-
posed to MAX, coated with a dimethoxydiphenylsilane/
triethoxycaprylylsilane crosspolymer, were still viable at
Figure 7 Changes in cell function in hONS cells treated with ZnO nanoparticles. For each ZnO treatment at each time-point (2 h, 6 h and
24 h), the responses of hONS cells from donors A, B, C and D, each seeded in three replicate wells, were averaged and expressed as the
percentage of time-matched untreated cells set as 100%. Data used to generate this figure, and associated standard errors of means and
statistical significance, are supplied separately in Additional file 3: Table S2.
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be an important factor in mitigating the toxicity of ZnO
nanoparticles, while particle size has less impact, at least in
the cellular system investigated here.
The minimal toxicity to hONS cells elicited by MAX,
compared with HP1, suggests that the magnitude of tox-
icity reductions conferred by surface coatings may be very
sensitive to the chemical composition of the coating mole-
cules; indeed, this has been observed in other cell lines for
ZnO nanoparticles bearing a variety of applied coatings
[20]. However, other, more subtle characteristics of the
coating may also be important. Our comparative analysis
of the surface coatings on HP1 and MAX indicates fewer
coating molecules per unit surface area on HP1, which
could be manifested by HP1 having a thinner coating, a
less densely-packed coating, or a patchy coating, and these
characteristics could also affect the extent of toxicity miti-
gation. Furthermore, even if a coating is uniform at the
point of manufacture, the strength of interaction between
the coating material and the ZnO surface may vary for dif-
ferent coatings (especially if the coating is physically
adsorbed) and the coating may partially detach with time
and/or in cell culture medium, resulting in a non-uniform
coverage of the surface. We have no direct data on the
structural characteristics of the coating on HP1 in the cel-
lular system used here. However, consistent with an in-
complete surface coverage for HP1 is our observation that
the responses in HP1-treated cells clustered with those of
cells treated with the uncoated nanoparticles, although de-
layed by a few hours; in contrast, the cellular responses to
MAX were either substantially delayed or minimal. Fur-
thermore, we note that the specific batch of HP1 usedhere dispersed more readily in cell-culture medium than
two other batches of HP1 used by our laboratory, consist-
ent with different extents of surface coverage. We are cur-
rently conducting a full physico-chemical analysis of HP1
from the three different batches [36]. Our initial observa-
tion of different dispersabilities raises the broader question
of the impact of batch-related differences in assessments of
nanoparticle toxicity. Given the list of challenges and con-
siderations currently associated with the in vitro testing of
nanomaterials, taking into account potential batch-to-batch
variations appears to be a daunting prospect, but highlights
the importance for full nanoparticle characterisation.
Overall, it is tempting to attribute the relative cellular re-
sponses to the ZnO samples largely, if not completely, to
different concentrations of zinc ions sourced from the dis-
solution of ZnO particles with varying exposed surface
areas. It is feasible that a larger area of exposed particle
surface might facilitate a more rapid increase in Zn2+ ion
concentration compared to a coated or smaller area of ex-
posed surface. Consistent with ZnO nanoparticle literature
pointing to zinc ion-mediated toxicity [12,13], a number
of the phenotypic outcomes reported here (loss of cellular
viability, increase in caspase 3–7 and decrease in cellular
glutathione (GSH)) also have been observed as cellular
outcomes following in vitro treatment of neuronal cells
with several types of zinc salt [37]. Furthermore, one of
the key factors in cytokine stimulation is the rate of intra-
cellular ion release after nanoparticle uptake by phagocytic
cells, which appears to be independent of cytotoxicity [33];
and the increased level of IL-6 at 2 h observed here for the
uncoated Nanosun, compared with the uncoated Z-COTE
and coated HP1, is consistent with its larger specific
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might be expected for Z-COTE and HP1, with the coating
on the latter also diminishing its dissolution rate. (In con-
trast, the cellular responses to the coated MAX are not
consistent with zinc ion-mediated cytotoxicity, and the
only significant response by the cells to MAX, namely
high levels of IL-6 at 2 h and IL-8 at 6 h, may have been
induced by the coating itself; this hypothesis has yet to be
tested.) However, at odds with a zinc ion-mediated toxicity
profile, hONS cells exposed to the uncoated Nanosun and
Z-COTE exhibited similar responses, despite a 2.5-fold
difference in powdered surface area. Furthermore, a recent
report has questioned the extent to which Zn2+ ions from
zinc salts are actually bio-available in cell culture medium
[38]. That report instead showed that ionic zinc swiftly
forms a range of insoluble carbonate and phosphate-based
nanoparticulate complexes when added to cell culture
medium. It is thus possible that zinc salts used as a control
for dissolved zinc may form and mimic the effects of
nanoparticles themselves, compromising their intended pur-
pose. The range of cytotoxicities associated with different
counter ions of zinc salts [37], alongside conflicting reports
on zinc salt toxicity [12,13] compared to ZnO nanoparticles
[39-41], and the possibility that zinc ions may themselves
form a range of nano-complexes in cell culture, together
suggest that further consideration of the role of Zn2+ in
ZnO nanoparticle toxicity experiments is warranted.
A distinct spectrum of key cell-stress signalling path-
ways was most rapidly activated by the uncoated ZnO
nanoparticles, followed by the coated HP1 particles. In
contrast, cells treated with MAX had much less substan-
tial cell-signalling responses, did not demonstrate a cellu-
lar stress response, and did not lose viability. This pattern
was also reflected at the transcriptional level, where simi-
lar pathways associated with oxidative stress and cell sur-
vival were activated by all treatments, but consistently
more so in cells treated with the uncoated nanoparticles
or HP1 compared to MAX. Treatments that induced the
strongest cell-signalling and transcriptional perturbations
also showed the greatest cell function responses, resulting
in the most significant losses in viability.
Specifically, in cells exposed to Z-COTE, Nanosun or
HP1, we observed an early activation of the MAPK and
Akt cell-signalling pathways, as well as the NF-kB path-
way. This cell-signalling fingerprint is associated with in-
flammation, proliferation and anti-apoptotic responses
and suggests that, in the first instance, these cells mounted
a protective response. The activation of these pro-survival
responses had substantially diminished by 6-10 h, con-
comitant with a decrease in cellular GSH levels, and in-
creased proteasome and caspase 3-7 activities, indicative
of oxidative stress, protein degradation and initiation of
apoptosis, respectively. Late responses in these cells (24 h)
included significantly compromised cell membrane and adecrease in most other homeostatic metabolic activities,
consistent with a treatment-related reduction in cell viabil-
ity. The increase in proteasomal activity in cells treated
with either of the uncoated nanoparticles or the coated
HP1, together with the induction of a range of molecular
chaperone genes, may suggest the induction of an un-
folded protein response [42]. Disregulation of protein fold-
ing has similarly been suggested elsewhere as a mode of
action following treatment of cells with micro or nano-
sized ZnO particles [43]; whether this response would be a
cause or effect of treatment-related loss of cellular viability
remains to be elucidated. Additionally, at 6 h, we found
that a number of histone-related genes tended to be up-
regulated with increasing treatment toxicity, but down-
regulated by treatment with the more benign MAX. Thus,
the cytotoxic nanoparticle treatments may have been asso-
ciated with a suppression of transcriptional activity in
addition to an unfolded protein response.
All ZnO nanoparticles induced an early perturbation
of Canonical Gene Pathways associated with oxidative
stress and cellular stress responses, with stronger per-
turbations associated with increasing treatment cyto-
toxicity. At 2 h and 6 h, a number of metallothioneins,
molecular chaperonins, zinc finger proteins and solute
carrier (SLC) genes were differentially regulated (gener-
ally positively) by all treatments, suggesting the induc-
tion of mechanisms to modulate intracellular levels of
zinc, as well as a generalised cellular stress response.
Using immortalised cell cultures treated with ZnO par-
ticles, Moos et al. (2011) reported a similar transcrip-
tional profile.
Interestingly, given its role as a key tumor-suppressor
protein regulating cellular apoptosis in response to cyto or
genotoxic insults, we did not observe a statistically signifi-
cant increase in p53 phosphorylated at Serine 15 (a site
closely associated with DNA-damage response [44]), nor
did we see an increase in the activation of either of the
cell-cycle checkpoint proteins, Chk1 or Chk2. This con-
trasts with previous reports of p53 protein up-regulation
following in vitro treatment with ZnO nanoparticles
[41,45,46] using different cell lines. However, consistent
with the absence of activation of the cell-signalling path-
ways involving p-p53, pChk1 and pChk2 here, we also ob-
served that a number of transcripts encoding DNA-
damage processing proteins were generally down-
regulated at 6 h, with the exception of the POLH gene,
which was up-regulated by all treatments. The POLH gene
encodes a polymerase that accurately replicates past
thymine-thymine dimers (typically associated with UV-
induced DNA damage) during translesion synthesis (TLS),
but is otherwise a low-fidelity polymerase when copying
undamaged DNA [47]. The up-regulation of a key TLS en-
zyme alongside the down-regulation of enzymes associ-
ated with DNA repair, as well as activation of proliferative
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suggest that the hONS cells responded to damage in DNA
induced by ZnO nanoparticles by preferentially by-passing
lesions rather than repairing them.
There is little reported elsewhere in the literature
concerning the impact of ZnO nanoparticles on the activa-
tion and function of DNA-damage processing mechanisms,
such as base excision repair, nucleotide excision repair, or
translesion synthesis. The general down-regulation of tran-
scripts associated with DNA-damage processing reported
here may suggest that, even though ZnO nanoparticles
have been shown elsewhere to induce DNA-damage
[20,41,45,48], primary hONS cells did not respond to this
genotoxic insult by activating DNA-damage repair mecha-
nisms, or alternatively that the DNA was not damaged in
these experiments. Consistent with the former, Hackenberg
[49] showed, following repeated exposure to sub-cytotoxic
doses of ZnO nanoparticles, that damage to DNA in hu-
man nasal mucosa mini-organ cultures was not repaired,
and in fact damage increased during a 24 h recovery period,
compared to repair observed in methyl methanesulfonate-
treated cells. Different surface coatings have been shown
previously to protect cell viability by reducing the gener-
ation of ROS from ZnO nanoparticles [21], but not neces-
sarily by reducing nanoparticle-mediated genotoxicity [20].
ZnO nanoparticle-mediated genotoxicity, therefore, may
not be a major trigger for concomitant cytotoxicity.
Whether ZnO nanoparticle-mediated DNA-damage might
be associated with direct inhibition of damage-processing
proteins by the particles themselves, or whether the gener-
alised stress responses of increasingly unviable cells over-
whelms or bypasses such mechanisms, or a combination of
the two, would be an interesting avenue to pursue.
Here, we utilised classical suspension to expose cells ra-
ther than the novel technique of delivering nanoparticle
aerosols to the air-liquid-interface (ALI) of cell cultures
e.g. [50]. The two techniques can produce differences in
assay parameters, including deposition kinetics, nanoparti-
cle agglomeration and dissolution, and the influence of
cell-culture medium on the surface characteristics of the
nanoparticles [51], which can influence biological end-
points. Literature comparing the effects of nanoparticles
delivered via the two techniques indicate general agree-
ment, but also some differences, in cellular responses over
time, including cell membrane integrity, gene expression
of pro-inflammatory and oxidative stress markers, and cell
viability [50,51]. It was further reported that while toxicity
assessments at the ALI are likely to produce the more
relevant biological responses, the influence of gas-derived
effects can mask those of the nanoparticles [51] and
that, for the moment, classical suspension exposures
remain a valuable complementary technique when as-
sessing the toxicity of nanoparticles to cells relevant for in-
halation exposure.The actual nanoparticle dose to cells in the olfactory
bulb will depend in part on the numbers of nanoparticles
inhaled through the nose, and their state of agglomeration.
Work by Guilherme and Kimbell [52] showed good agree-
ment between experimentally derived calculations and
computer modelling predictions for particle sizes up to
100 nm, suggesting that approximately 20% of nano-
particles deposited in the olfactory region will translocate
to the olfactory bulb [23]. While we determined sizes of
the individual ZnO nanoparticles and time-dependent
changes in sizes of agglomerates forming in cell-culture
medium, we did not characterise the particle sizes in aero-
sol form. Thus, it is difficult to estimate what the nasally-
inhaled dose of ZnO particles would be, with subsequent
translocation to the olfactory mucosa, that would produce
the dose used here for the suspension assays.Conclusions
In conclusion, we have reported a comprehensive over-
view of the response of primary human multi-potent
cells to uncoated and coated ZnO nanoparticles in an
important in vitro model with respect to nasal-
inhalation exposure. Our findings support two major
conclusions. First, we find that surface coatings on
ZnO nanoparticles may delay or substantially mitigate
the onset of cellular responses depending on the coat-
ing composition and other coating characteristics. Sec-
ond, whilst ZnO nanoparticle toxicity can be mediated
by a range of cellular stress, inflammation and apop-
totic responses, mechanisms to process damaged DNA
do not appear to be activated, and may be down-
regulated. Given the results from our in vitro model,
we suggest that inhaled, uncoated ZnO nanoparticles
may adversely impact local multipotent cell popula-
tions in the olfactory mucosa in vivo. Thus, depending
on the volumes handled, personal protection or engin-
eering controls are recommended for workplaces
where aerosols of uncoated ZnO nanoparticles are gen-
erated. ZnO nanoparticle toxicity, however, can be
largely mitigated by the addition of stable surface
coatings.Methods
ZnO nanoparticles
Two types of uncoated ZnO nanoparticles were used
in this study: Z-COTE (BASF, batch# EHDA3001)
and Nanosun P99/30 (Micronisers, batch# 4051).
Two types of coated ZnO nanoparticles were also
used: Z-COTE HP1 (BASF, batch# CNHE0602)
coated with triethoxycaprylylsilane; and Z-COTE MAX
(BASF, batch# FCHE1301) coated with a dimetho-
xydiphenylsilane/triethoxycaprylylsilane crosspolymer.
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Particle size, size distribution, and shape
Sizes and shapes of the ZnO particles were characterised
by transmission electron microscopy (TEM) using a
Tecnai 12 TEM (FEI, Eindhoven, Netherlands) operating
at 120 kV under a variety of magnifications. Prior to meas-
urement, TEM calibration was confirmed by the accurate
size determination of 30 nm gold nanoparticle standards
supplied by the National Institute of Standards and Tech-
nology, USA (RM8012) [53]. Dispersions of nanoparticle
powders were prepared by adding small amounts (~1 mg)
to 30 μL ethanol and bath sonicating gently for 5 min to
form a milky suspension. Samples were prepared for TEM
imaging by applying a 4 μL aliquot of suspension to 400-
mesh carbon-coated grids freshly glow-discharged for
15 sec in nitrogen. The sample was allowed to settle for
approximately 1 min after which excess sample was
whicked off with filter paper. Images were recorded using
a MegaView III CCD camera (Olympus) and sizes were
determined using AnalySis software (Olympus) and Image
J software (NIH) calibrated via the embedded scale bar.
Only the particle diameter was measured for spherical
particles (Nanosun), whereas both width and length were
measured for variously shaped particles (Z-COTE, HP1
and MAX). 90–300 measurements were taken for each
dimension.
Specific surface areas of particles
The Brunauer-Emmett-Teller (BET) equation was used
to calculate specific surface areas of the ZnO powders
from nitrogen adsorption isotherms measured at 77 K
using a Micromeritics ASAP 2010 volumetric adsorption
analyser [54]. The BET calculation was performed from
the adsorption isotherm at relative pressure (P/Po) ran-
ging from 0.05 to 0.2. Before measurement, samples
were out-gassed at 120°C for over 24 h. A second set of
measurements was performed by a different operator in
a different laboratory using a different Micromeritics in-
strument, to check original measurements.Free radical generation by particles
Levels of peroxynitrile and superoxide radicals generated by
the ZnO particles were determined in triplicate by electron
paramagnetic resonance (EPR) using TEMPONE-H (Enzo
Life Sciences) as a spin trap. Test samples (0.01 mg/mL)
were prepared in sterile saline. TEMPONE-H (1 μL of
100 mM stock solution) was added to 99 μL of the test
sample to obtain a final concentration of 1 mM
TEMPONE-H. The samples were incubated at 37°C for
60 min either in complete darkness or in sunlight fil-
tered through a window, after which the levels of
oxidised TEMPONE-H were quantified by EPR. A nega-
tive control was prepared using saline only.Analysis of surface coatings in HP1 and MAX
Elemental compositions of the coated HP1 and MAX
were determined using 0.15 g of sample dissolved in a 1:1
HNO3: H2O2 mixture with heating for 30 min. The solu-
tion was diluted to 100 mL, internal standard Sc was
added, and the resultant solution was analysed by Induct-
ively Coupled Plasma-Atomic Emission Spectroscopy
(Varian 730 Axial ICP-AES).
Thermal properties of the coated HP1 and MAX were
analysed with a thermogravimetric analyser (Mettler
Toledo TGA SDTA851 with a Mettler TSO 801 RO sam-
ple robot (Mettler Toledo, Melbourne, Australia)). Approxi-
mately 60 mg (accurately weighed) of powdered samples in
ceramic crucibles were heated in a carrier gas of air at the
rate of 10°C/min from room temperature to a maximum of
1100°C, and weight loss as a function of temperature was
recorded.
Endotoxin testing
For measurement of endotoxin levels, 1 mg/mL each
sample was vortexed for 1 min in limulus amebocyte
lysate (LAL) endotoxin-free water and incubated for 1 h
at 37°C. Samples were then centrifuged and endotoxin
levels in the supernatant were determined in triplicate
using the QLC-1000 Chromogenic LAL kit (Lonza) fol-
lowing manufacturer’s instructions. A previous trial had
shown that centrifugation did not artificially lower
endotoxin levels in the supernatant (data not shown).
An aliquot of each supernatant was also spiked with a
known amount of endotoxin and measured alongside
unspiked samples to check if the nanoparticles inhibited
the assay. The spiked sample for Z-COTE indicated
minor assay inhibition, but retesting using diluted sam-
ples showed that endotoxin levels remained below the
assay detection limit (<10 pg/mL). Nanosun, HP1 and
MAX did not inhibit the assay.
Characterisation of nanoparticles dispersed in cell
culture medium
Nanoparticle suspensions (25 μg/mL) were prepared in
DMEM/F12 (1:1), and incubated (37°C, 10% CO2) for 0,
2, 6 and 24 h. Within 30 min of removal from the incu-
bator, hydrodynamic particle size and surface charge
were determined by dynamic light scattering (DLS) and
measurement of zeta potential, respectively (Zetasizer
Nano series, Malvern Instruments). All measurements
were performed at 37°C to simulate the temperature at
which cells were incubated. Hydrodynamic particle size
in DMEM/F12 medium at 0 h was also assessed by dif-
ferential centrifugal sedimentation (DCS) (CPS DC24000
UHR Disc Centrifuge, LPS Instruments, Inc.). The pH of
cell-culture medium containing nanoparticles was mea-
sured at 0, 2, 6 and 24 h using a calibrated pH meter
(Waterproof pHTestr2, Oakton Instruments).
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Neurosphere-derived cells generated from four individual
olfactory mucosa biopsies (from human donors A, B, C
and D) were propagated as adherent monolayers in
DMEM/F12 (1:1, Gibco) containing 10% FBS, as described
elsewhere [31]. The biopsies were obtained after informed
consent, and the procedure was approved by the Griffith
University Human Ethics Committee and according to
guidelines of the National Health and Medical Research
Council of Australia. For all experiments described here,
cells were used between passages 4-15 from neurospheres
that had been generated once from primary cultures be-
tween passages 5-8, depending on the donor cell line. All
incubations were performed at 37°C, 10% CO2.
Preparation of nanoparticle test suspensions and controls
A stock suspension (1 mg/mL) of each ZnO product
was prepared by adding cell-culture medium to pre-
weighed powder in a clean, sterile 50 mL Falcon tube.
Tubes were briefly vortexed and then bath sonicated for
15 min to disperse the nanoparticles. The stock suspen-
sion was diluted with medium to the appropriate test
concentrations and then sonicated for a further 15 min
before being added to cell cultures.
Selection of nanoparticle concentration for detailed
investigations of biological responses
Cells from donor A were seeded (2500 cells/well) into
two 96-well plates (one clear, one opaque black) and in-
cubated overnight. Medium was removed and replaced
in duplicate wells with medium containing 10, 20, 30, 50
or 80 μg/mL nanoparticles, or medium containing no
nanoparticles, and incubated, providing duplicate mea-
surements for each assay and each treatment. At 22 h,
MTS reagent (20 μL; CellTiter Aqueous MTS assay,
Promega) was added to each well of the clear plate as a
measure of cell viability via mitochondrial activity, and
cells were incubated for a further 2 h; and, at 23 h,
CyQUANT reagent (50 μL; Invitrogen) was added to
each well of the black plate to determine cell number via
DNA content, and cells were incubated for a further 1 h,
following the manufacturer’s instructions. After a total
of 24 h incubation, plate absorbance/fluorescence was
recorded according to the manufacturer’s instructions
using a Synergy II plate reader (BioTek).
Data from cells in each well were corrected for back-
ground, using signal values from wells containing medium
alone or from matched concentrations of nanoparticles in-
cubated and assayed in the absence of cells.
Cytokine assays
Cells from donor A were seeded (120,000 cells/well) into 6-
well plates and incubated overnight. Medium was removed,
and replaced with medium containing either 25 μg/mLnanoparticles, or no nanoparticles, and then incubated for
2 h or 6 h. Three replicate wells were used for each treat-
ment. After incubation, conditioned medium was taken
from the wells and frozen at −80°C.
Cytokine protein levels were determined using a Th1/
Th2 11-plex bead array kit (Bender MedSystems). Beads
were analysed via flow cytometry on a Canto II digital
flow cytometer (BD Biosciences). Individual bead popu-
lations were discriminated by size and fluorescence at
620/633 nm (excitation/emission) and the amount of
cytokine binding was assessed by phycoerythrin (PE)
fluorescence (488/575 nm). Cytokine signal was mea-
sured as mean PE fluorescent intensity in each popula-
tion and compared to known standards. Curve fitting
and calculation of cytokine concentrations in the media
were performed using GraphPad Prism 5.01 (GraphPad
Software, USA) and assessed for statistical significance
by one-way ANOVA with Bonferroni’s multiple com-
parison test, set at p<0.05.
Cell signalling assays
Cells from donor A were seeded (55,000 cells/well) into
12-well plates and cultured overnight. Medium was re-
moved and replaced with medium containing either 25
μg/mL nanoparticles, or no nanoparticles, for 2, 4, 6, 8,
and 10 h. Three replicate wells were used for each treat-
ment. At the appropriate time-points, the medium was re-
moved from the wells and the cells were lysed with 500 μL
1X AlphaScreen SureFire Lysis buffer. The lysates were
frozen at -80°C until further analysis.
The cell lysates were analyzed for phosphorylation (p)
of several intercellular signalling proteins using the
AlphaScreen SureFire platform (PerkinElmer) following
manufacturer’s instructions. The specific proteins exam-
ined were Akt (p-Ser473), BAD (p-Ser112), MEK1 (p-
Thr217/Tyr221), ERK (p-Thr202/Tyr204), p38 MAPK
(p-Thr185/Tyr187), c-JUN (p-Ser63), JNK (p-Thr185/
Tyr187), NF-kB p65 (p-Ser536), I-kΒα (p-Ser32/36), p53
(p-Ser15), Chk1 (p-Ser), and Chk2 (p-Ser45). Levels of
total (t) ERK, Akt and I-kΒα were also measured as con-
trols to ensure signalling protein levels were not gener-
ally changing over the time course of the experiments.
Briefly, the lysates were thawed, and portions of lysate
(4 μL) were transferred to wells in assay plates (384-
Proxiplates, PerkinElmer) and analyzed in parallel for
the formation of specific phosphorylated epitopes on
several key intracellular signalling proteins, as previously
described in detail [55]. The signals in the wells were de-
termined using an Envision multilabel plate reader
(PerkinElmer), using standard Alpha settings.
Time-course responses were analyzed using GraphPad
Prism 5.01 (GraphPad Software, USA). Differences over
time between treatments versus no treatment were
assessed for statistical significance by 2-way ANOVA
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Prism 5.01 (GraphPad Software, USA), where statistical
significance was set at p<0.05.
Gene expression assays using microarrays
Cells from donor A were treated as described above for
the cytokine assays. Four replicate wells for each treatment
were used. After aspiration of medium, cells were lysed in
the well, and RNA was isolated using a NucleoSpin® RNA
II kit (Macherey-Nagel, Scientifix) following manufac-
turer’s instructions. RNA concentration was determined
using a NanoDrop DN-1000 spectrophotometer (Biolab),
and RNA integrity (i.e. no, or limited, degradation) was
confirmed (RNA 6000 Nanochip™, 2100 Bioanalyzer;
Agilent Technologies). Four samples per treatment (a total
of 56 samples) were prepared for microarray analysis using
the Affymetrix GeneChip Human Gene 1.0 ST Array
Combo kit (Millennium Science) containing arrays and re-
agents, following manufacturer’s instructions. Microchips
were prepared for hybridisation and scanning using an
Affymetrix GeneChip® Hybridisation, Wash and Stain Kit
(Millennium Science), following manufacturer’s instruc-
tions. After hybridisation (17 h, 45°C, 60 rpm in an
Affymetrix 640 GeneChip® Hybridization Oven), micro-
chips were washed using an Affymetrix GeneChip® Fluid-
ics Station 450 and scanned using an Affymetrix 7G
GeneChip® Scanner. All microchips passed the associated
quality control procedures recommended by Affymetrix.
The microchips were processed in eight batches of
seven by the same operator, and following the same pro-
cedure. Each batch was processed on a different day,
and contained one microchip from each of the four
time-matched treatments (HP1, Z-COTE, Nanosun and
MAX), controls, plus two other treatments which were
not subjects of the present study. The gene expression
data were normalized by applying the robust multi-array
average (RMA) algorithm using Matlab 7.7.0 (The
Mathworks Inc., Natick, MA, USA) on the entire data
set from all 56 microchips (28 from the 2 h treatments
and 28 from the 6 h treatments), treated as a whole.
Final gene datasets were analyzed through the use of In-
genuity Pathways Analysis (Ingenuity® System, www.in-
genuity.com), taking into account whether the genes were
under-expressed or over-expressed. Overlapping responses
between treatments were identified on the basis of shared
over-expressed and under-expressed genes, as well as
shared activation of a gene network.
Gene expression datasets, like other high throughput
datasets, suffer from what are known as batch effects
[56,57]. In essence, batch effects are structured patterns of
distortion caused by the interaction of various sources of
noise associated with the laboratory processing of high
throughput arrays. This distortion is unique to each batch,
with significant variation from batch to batch. Therefore,even when the processing batches are balanced across
treatments as is the case in this study, batch effects mas-
querade as within-treatment variance reducing signifi-
cantly the power of statistical comparison tests. There are
techniques based on model fitting to remove batch effects,
but these always have the risk of over-correction, resulting
in the removal of genuine biological variance. Removing
genuine variance has the undesirable effect of leading to
false positives – genes that appear to be differentially-
expressed when in fact they are not. In this study we have
employed a technique [58] that quantifies the risk of over-
correction, and then enables the maximal removal of
batch noise with the constraint that this risk is controlled
at a probability level set by the experimenter (in our case
we set this probability to be .05).
For each treatment, and for each probe-set included in
the microchips, the four treatment scores were compared
against four control scores via t-tests. Given that the
probe-sets on the arrays number in the thousands, the next
challenge was to implement a multiplicity correction
process that strikes a sensible balance between Type 1 and
Type 2 errors – that is between controlling false positives
and false negatives. Traditional correction techniques (such
as Bonferroni) do reject false positives when applied to
microarray data, but this comes at the expense of a typic-
ally high number of false negatives. We employed a hybrid
method [59] which took its inspiration from biologists’
“fold-change” test. Based on empirical distributions from
the probe-set scores, we derived expected rates of false dis-
covery as a function of the absolute log2 difference between
the treatment mean and the control mean. The gene asso-
ciated with the probe-set was deemed differentially-
expressed for a given treatment if there was an absolute
log2 difference of ‘x’ between the treatment mean and the
control mean (i.e. that one mean was 2x times the other),
where ‘x’ corresponded to a false discovery rate of 0.1, with
the further condition that this difference was statistically
significant as tested by a 2-way t-test set at p=0.05. If this
difference was positive, the gene was deemed over-
expressed, and if negative, under-expressed. In this way, we
were able to establish lists of differentially-expressed genes
for individual treatments, which could be compared to one
another. In the traditional fold-change test, ‘x’ is typically
set to 1.0 for all treatments, but this is problematic in com-
paring different treatments because, depending on the
probe-set distributions, a log2 difference of 1.0 between
treatment and control will correspond to different false dis-
covery rates across different treatments.
Cell stress and viability assays
Cells from donors A, B, C and D were seeded (2500 cells/
well) into 96-well plates (clear, or opaque black or white,
depending on assay requirement) and incubated overnight.
Medium was removed and replaced with medium
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nanoparticles, and incubated for 2, 6 or 24 h. Three repli-
cate wells for each treatment were used for each assay and
for each cell line. Towards the end of each incubation
period, plates and reagents were equilibrated to room
temperature and cell function assay reagents were added to
each plate to test for NAD(P)H-dependent dehydrogenase
activity (CellTiter Aqueous MTS assay, Promega), ATP
levels (ATPlite assay, Perkin Elmer), lactate dehydrogenase
(LDH) activity (CytoTox-ONE homogenous membrane in-
tegrity assay, Promega), reduced and total glutathione
(GSH) content (GSH-Glo glutathione assay, Promega),
chymotrypsin-like, trypsin-like and caspase-like proteasome
activities (Proteasome-Glo cell-based assays, Promega), and
caspase 3-7 activity (Apo-ONE homogenous caspase-3/7
assay, Promega) according to manufacturer-supplied proto-
cols with only minor modifications as described previously
[60] where well absorbance/luminescence/fluorescence was
recorded using a Synergy II plate reader (BioTek).
Signals from wells containing cells were corrected for
background by subtracting the signal from wells containing
medium alone, and signals from wells with cells and
nanoparticles were corrected by subtracting the signal from
25 μg/mL nanoparticles in medium in the absence of cells.
Mean background-corrected results for each donor from
triplicate wells were then averaged across the four donors
to give a final value for each treatment. To correct for a
possible decrease in signal due to loss of live cells rather
than treatment-mediated effects on cell function, data for
cell function assays were normalised to treatment-matched
DNA content in live cells (CyQUANT-NF, Invitrogen).
Data from each treatment were assessed for statistical
significance by 2-way ANOVA with Bonferroni’s mul-
tiple comparisons test set at p<0.05, using GraphPad
Prism 5.01 (GraphPad Software, USA).
Additional files
Additional file 1: Figure S1. hONS cell viability across a range of ZnO
nanoparticle concentrations (10–80 μg/mL). For each ZnO treatment at
24 h, the responses of hONS cells from donor A, in two replicate wells,
were averaged and expressed as the percentage of time-matched
untreated cells set as 100%. Cell viability was assessed using A. the MTS
assay, and B. the CyQuant Assay.
Additional file 2: Table S1. Phosphorylation of proteins in key cell-
signalling pathways in hONS cells exposed to ZnO nanoparticles.
Additional file 3: Table S2. Functional changes in hONS cells exposed
to ZnO nanoparticles.
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